Cymbalta Fibromyalgia sNDA Could Make Lilly Product Lyrica’s First Competitor
This article was originally published in The Pink Sheet Daily
Executive Summary
Patients treated with Cymbalta show greater reduction in pain compared to placebo in a six-month pivotal trial, Lilly reports.